Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes
Here, the perspective of patients with primary and secondary immunodeficiency receiving subcutaneous immunoglobulin (SCIg) via introductory smaller size pre-filled syringes (PFS) or vials were compared.
Source: BMC Immunology - Category: Allergy & Immunology Authors: R. Mallick, G. Solomon, P. Bassett, X. Zhang, P. Patel and O. Lepeshkina Tags: Research Source Type: research
More News: Allergy & Immunology